Clinical toxicity of antiretroviral nucleoside analogs
- 1 July 1996
- journal article
- review article
- Published by Elsevier in Antiviral Research
- Vol. 31 (3), 121-135
- https://doi.org/10.1016/0166-3542(96)85209-0
Abstract
No abstract availableThis publication has 101 references indexed in Scilit:
- MEDICINE AND THE LAW: Deaths in US fialuridine trialThe Lancet, 1994
- Fulminant hepatitis with severe lactate acidosis in HIV‐infected patients on didanosine therapyJournal of Internal Medicine, 1994
- A Comparative Trial of Didanosine or Zalcitabine after Treatment with Zidovudine in Patients with Human Immunodeficiency Virus InfectionNew England Journal of Medicine, 1994
- Didanosine-induced Disorders of Glucose ToleranceAnnals of Internal Medicine, 1993
- 2',3'‐Dideoxycytidine (ddC) toxic neuropathyNeurology, 1993
- Long-Term Follow-Up of Didanosine Administered Orally Twice Daily to Patients with Advanced Human Immunodeficiency Virus Infection and Hematologic Intolerance of ZidovudineClinical Infectious Diseases, 1993
- 2',3'-Didehydro-3'-deoxythymidine (d4T) in Patients with AIDS or AIDS-Related Complex: A Phase I TrialThe Journal of Infectious Diseases, 1993
- Abnormalities of Liver Function during HIV Seroconversion IllnessInternational Journal of STD & AIDS, 1992
- Depletion of muscle mitochondrial DNA in AIDS patients with zidovudine-induced myopathyThe Lancet, 1991
- Dideoxyinosine in Children with Symptomatic Human Immunodeficiency Virus InfectionNew England Journal of Medicine, 1991